1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019; 69:7–34.
Article
2. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019; 51:417–30.
Article
4. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17:1471–4.
Article
5. Li J, Guo BC, Sun LR, Wang JW, Fu XH, Zhang SZ, et al. TNM staging of colorectal cancer should be reconsidered by T stage weighting. World J Gastroenterol. 2014; 20:5104–12.
Article
6. Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestol K, Maddison J, et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet. 2020; 395:350–60.
Article
7. Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 2013; 14:1295–306.
Article
8. Haruki K, Kosumi K, Li P, Arima K, Vayrynen JP, Lau MC, et al. An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer. Br J Cancer. 2020; 122:1367–77.
Article
9. Dercle L, Lu L, Schwartz LH, Qian M, Tejpar S, Eggleton P, et al. Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway. J Natl Cancer Inst. 2020; 112:902–12.
Article
10. Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Smail-Tabbone M, et al. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology. 2020; 158:76–94.
Article
11. Reichling C, Taieb J, Derangere V, Klopfenstein Q, Le Malicot K, Gornet JM, et al. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut. 2020; 69:681–90.
Article
12. Stojadinovic A, Bilchik A, Smith D, Eberhardt JS, Ward EB, Nissan A, et al. Clinical decision support and individualized prediction of survival in colon cancer: Bayesian belief network model. Ann Surg Oncol. 2013; 20:161–74.
Article
14. Deist TM, Dankers F, Valdes G, Wijsman R, Hsu IC, Oberije C, et al. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: an empirical comparison of classifiers. Med Phys. 2018; 45:3449–59.
Article
15. Czarnecki WM, Podlewska S, Bojarski AJ. Robust optimization of SVM hyperparameters in the classification of bioactive compounds. J Cheminform. 2015; 7:38.
Article
16. Steyerberg EW, Harrell FE Jr. Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2016; 69:245–7.
Article
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143:29–36.
Article
18. Elsebaie MA, Amgad M, Elkashash A, Elgebaly AS, Ashal G, Shash E, et al. Management of low and intermediate risk adult rhabdomyosarcoma: a pooled survival analysis of 553 patients. Sci Rep. 2018; 8:9337.
Article
19. Lei L, Wang Y, Xue Q, Tong J, Zhou CM, Yang JJ. A comparative study of machine learning algorithms for predicting acute kidney injury after liver cancer resection. PeerJ. 2020; 8:e8583.
Article
20. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020; 70:145–64.
Article
21. Schwender H. Imputing missing genotypes with weighted k nearest neighbors. J Toxicol Environ Health A. 2012; 75:438–46.
22. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99:433–41.
Article
23. Kelder W, Inberg B, Schaapveld M, Karrenbeld A, Grond J, Wiggers T, et al. Impact of the number of histologically exa-mined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands. Dis Colon Rectum. 2009; 52:260–7.
24. Dai W, Mo S, Xiang W, Han L, Li Q, Wang R, et al. The critical role of tumor size in predicting prognosis for T1 colon cancer. Oncologist. 2020; 25:244–51.
Article
25. Cha YJ, Park EJ, Baik SH, Lee KY, Kang J. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy. Sci Rep. 2019; 9:11617.
Article
26. Kang J, Kim H, Hur H, Min BS, Baik SH, Lee KY, et al. Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence? Yonsei Med J. 2013; 54:131–8.
Article
27. Hwang MR, Park JW, Park S, Yoon H, Kim DY, Chang HJ, et al. Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol. 2014; 21:1345–51.
Article
28. Lee JM, Chung T, Kim KM, Simon NS, Han YD, Cho MS, et al. Significance of radial margin in patients undergoing complete mesocolic excision for colon cancer. Dis Colon Rectum. 2020; 63:488–96.
Article
29. Badic B, Hatt M, Durand S, Jossic-Corcos CL, Simon B, Visvikis D, et al. Radiogenomics-based cancer prognosis in colorectal cancer. Sci Rep. 2019; 9:9743.
Article
30. Dienstmann R, Vermeulen L, Guinney J, Kopetz S, Tejpar S, Tabernero J. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer. 2017; 17:79–92.
Article